Carbogen Amcis expands operations in Bubendorf

The acquired multi-story building is divided into laboratory, production, storage and office areas and provides a set of cleanroom GMP-compliant suites.

On 26 May 2016, Carbogen Amcis undersigned the acquisition of the land and buildings of GEA Pharma Systems AG in Bubendorf, Hauptstrasse 145. The acquisition, which is close to the company's current headquarters, will become effective on 1 January 2017.

Located on 5200 m² of land, the 3360 m² multi-story building is divided into laboratory, production, storage and office areas and provides a set of cleanroom GMP-compliant suites. The company is planning modification work to adapt the building to its specific requirements and convert more of the facility into GMP operations areas.

“The immediate proximity to our current headquarters and our larger scale production site in Bubendorf, Switzerland, is ideal. It will allow us to significantly extend our laboratory capacity for highly potent development and small scale production as well as analytical support,” said Stephan Fritschi, Vice-President Operations at Carbogen Amcis. “Operations are scheduled to expand into the new building in 2017.”

“In the last couple of years we have experienced a significant and continuous increase in customers’ demand for additional capacity, including demand for labs and small-scale development,” said Mr Janmejay Vyas, Chairman of the Dishman Group of Companies. “This acquisition is targeted to support our business growth and company expansion. It will allow Carbogen Amcis to keep its position as an industry leader and outsourcing partner for complex highly potent APIs and ADCs.”

“I am delighted that we are able to extend our operations in Bubendorf to fulfil our customer needs and their growing expectations,” Commented Mark Griffiths, Global CEO of Carbogen Amcis and the Dishman Group. “Moreover, this facility will bring new opportunities to further enhance our capabilities and capacities. In the near future, the company plans to introduce a number of additional capabilities including, but not limited to, commercial manufacture of ADCs and additional Cat 4 (ng OEL) development capacity. The new facility is closely located with our current Carbogen Amcis Headquarters in Bubendorf and as such enables us to leverage the existing support network to the new site."